Sunday, August 14, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

BOSTON - Aveo Pharmaceuticals and its board misrepresented the prospects of the cancer drug tivozanib, and the share price dropped precipitously when the truth came out, a class action claims in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...